Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

T. Grinda, A. Antoine, W. Jacot, C. Blaye, P.-H. Cottu, V. Diéras, F. Dalenc, A. Gonçalves, M. Debled, A. Patsouris, M.-A. Mouret-Reynier, A. Mailliez, F. Clatot, C. Levy, J.-M. Ferrero, I. Desmoulins, L. Uwer, T. Petit, C. Jouannaud, M. Lacroix-Triki, E. Deluche, M. Robain, C. Courtinard, T. Bachelot, E. Brain, D. Pérol, S. Delaloge

Open source

DOI
10.1016/j.esmoop.2021.100114
Published
2021-06
Container
ESMO Open
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.esmoop.2021.100114,
  title = {Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort},
  author = {T. Grinda and A. Antoine and W. Jacot and C. Blaye and P.-H. Cottu and V. Diéras and F. Dalenc and A. Gonçalves and M. Debled and A. Patsouris and M.-A. Mouret-Reynier and A. Mailliez and F. Clatot and C. Levy and J.-M. Ferrero and I. Desmoulins and L. Uwer and T. Petit and C. Jouannaud and M. Lacroix-Triki and E. Deluche and M. Robain and C. Courtinard and T. Bachelot and E. Brain and D. Pérol and S. Delaloge},
  year = {2021},
  journal = {ESMO Open},
  doi = {10.1016/j.esmoop.2021.100114},
  url = {https://doi.org/10.1016/j.esmoop.2021.100114}
}

RIS

TY  - JOUR
TI  - Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort
AU  - T. Grinda
AU  - A. Antoine
AU  - W. Jacot
AU  - C. Blaye
AU  - P.-H. Cottu
AU  - V. Diéras
AU  - F. Dalenc
AU  - A. Gonçalves
AU  - M. Debled
AU  - A. Patsouris
AU  - M.-A. Mouret-Reynier
AU  - A. Mailliez
AU  - F. Clatot
AU  - C. Levy
AU  - J.-M. Ferrero
AU  - I. Desmoulins
AU  - L. Uwer
AU  - T. Petit
AU  - C. Jouannaud
AU  - M. Lacroix-Triki
AU  - E. Deluche
AU  - M. Robain
AU  - C. Courtinard
AU  - T. Bachelot
AU  - E. Brain
AU  - D. Pérol
AU  - S. Delaloge
PY  - 2021
JO  - ESMO Open
DO  - 10.1016/j.esmoop.2021.100114
UR  - https://doi.org/10.1016/j.esmoop.2021.100114
ER  - 

APA

Grinda, T., Antoine, A., Jacot, W., Blaye, C., Cottu, P., Diéras, V., Dalenc, F., Gonçalves, A., Debled, M., Patsouris, A., Mouret-Reynier, M., Mailliez, A., Clatot, F., Levy, C., Ferrero, J., Desmoulins, I., Uwer, L., Petit, T., Jouannaud, C., Lacroix-Triki, M., Deluche, E., Robain, M., Courtinard, C., Bachelot, T., Brain, E., Pérol, D., & Delaloge, S. (2021). Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort. ESMO Open. https://doi.org/10.1016/j.esmoop.2021.100114

Source records